We have observed
5 EP applications
Robert James Gleave
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after April 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
NOVEL SMALL MOLECULE INHIBITORS OF BIOFILM FORMATION AND THE NOVEL USE OF PREVIOUSLY IDENTIFIED COMPOUNDS FOR INHIBITION OF BIOFILM FORMATION AND APPLICATIONS FOR DRUG THERAPY AND MEDICAL DEVICE COATING
LITHIUM TRANSITION METAL PHOSPHATE SECONDARY AGGLOMERATES AND PROCESS FOR ITS MANUFACTURE
SYSTEM AND PROCESS FOR CARBON DIOXIDE REMOVAL OF AIR OF PASSENGER CABINS OF VEHICLES
ELECTROLYTIC ON-SITE GENERATOR